Literature DB >> 28124006

Twenty years of Milan criteria and live-donor liver transplantation in the US: a contrast in transparency, regulation, and expectation.

David C Cronin1, Timothy M Cronin2.   

Abstract

Entities:  

Year:  2016        PMID: 28124006      PMCID: PMC5218913          DOI: 10.21037/hbsn.2016.12.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Transplantation of liver grafts from living donors into adults--too much, too soon.

Authors:  D C Cronin; J M Millis; M Siegler
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  Ethics of liver transplantation with living donors.

Authors:  P A Singer; M Siegler; P F Whitington; J D Lantos; J C Emond; J R Thistlethwaite; C E Broelsch
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

3.  Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States.

Authors:  Julie K Heimbach; Ryutaro Hirose; Peter G Stock; David P Schladt; Hui Xiong; Jiannong Liu; Kim M Olthoff; Ann Harper; Jon J Snyder; Ajay K Israni; Bertram L Kasiske; W Ray Kim
Journal:  Hepatology       Date:  2015-02-24       Impact factor: 17.425

Review 4.  Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.

Authors:  Elizabeth A Pomfret; J Peter A Lodge; Federico G Villamil; Mark Siegler
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

5.  Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.

Authors:  L M Kulik; R A Fisher; D R Rodrigo; R S Brown; C E Freise; A Shaked; J E Everhart; G T Everson; J C Hong; P H Hayashi; C L Berg; A S F Lok
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

6.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

Review 7.  Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.

Authors:  Michael L Volk; Jorge A Marrero; Anna S Lok; Peter A Ubel
Journal:  Transplantation       Date:  2006-11-15       Impact factor: 4.939

8.  Adult living donor liver transplantation using a right hepatic lobe.

Authors:  M E Wachs; T E Bak; F M Karrer; G T Everson; R Shrestha; T E Trouillot; M S Mandell; T G Steinberg; I Kam
Journal:  Transplantation       Date:  1998-11-27       Impact factor: 4.939

9.  Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

Authors:  R A Fisher; L M Kulik; C E Freise; A S F Lok; T H Shearon; R S Brown; R M Ghobrial; J H Fair; K M Olthoff; I Kam; C L Berg
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

10.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.